Drug Pipeline

We develop new medicines in several therapeutic areas where we believe we can make significant impact on the disease and its management. We collaborate with our strategic partners for the discovery of new small and large molecules. Our R&D team has balanced collaboration with external parties across industry, academia and healthcare authorities.

Our R&D team has experience developing medicines in oncology, cardiology, neurology, central nervous system, inflammatory and immunology.

Click to see larger versionDrug pipeline for website